Arkolith/Insider Trading/AEON/Form 4

Fischer Jost

DirectorAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed May 21, 2025
Net Buying
Open-Market Buys
$56K
Open-Market Sells
$0
Net Open-Market Flow
$56K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Buy(P)60K$0.51$31K207K
May 19, 2025Buy(P)50K$0.50$25K147K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000124) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML